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Objective. To retrospectively evaluate early and late results of surgical treatment of secondary aorto-enteric fistulas
(SAEFs) with prosthetic excision and extra-anatomic bypass (conventional treatment) in a single centre institution
(teaching hospital).
Materials and methods. Between January 1990 and March 2002, 30 patients underwent conventional surgical treatment
for SAEF. Data concerning these operations were collected in a dedicate database and 30-day mortality, patency and limb
salvage rates were evaluated by mean of chi-square test and logistic regression analysis. Clinical and ultrasonographic
follow-up was performed; late results were evaluated by mean of Kaplan–Meyer curves.
Results. Thirty day mortality rate was 26% (8 patients). Timing and sequence of interventions (simultaneous or staged,
prosthetic excision or revascularization before) had no significative influence on perioperative mortality. There were six
extranatomic bypass thromboses at 30 days, but no amputation. Mean duration of follow-up was 24 months; estimated 12-
and 24-month survival rates were 60 and 50%, respectively. There were better results in terms of long-term survival in
patients undergone prosthetic graft excision before. Primary patency rate was 62% and limb salvage rate was 95%, both at
24 months. Two prosthetic graft reinfections occurred during follow-up (9%). Cumulative reinterventions rate during
follow-up was 18%.
Conclusions. Conventional surgical treatment of SAEF permitted, in our experience, satisfactory early and long terms
results, with fair rates of patency and limb salvage. Surgical timing and sequence do not seem to affect early results.
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Introduction
Secondary aorto-enteric fistula (SAEF) remains a
devastating complication of reconstructive aortic
surgery, with a low but stable incidence during the
years.
Traditional surgical treatment consists of prosthetic
graft excision and extranatomical revascularization of
lower limbs (conventional treatment).1
Different surgical techniques (in situ replacement
with antibiotic-bonded prostheses, autologous veins
or arterial allografts; endovascular treatment) have
been proposed in last years to reduce mortality and
amputation rate of conventional treatment.2
However, no evidence does exist concerning the
best therapeutic option, and, when considering con-
ventional treatment alone, there is no consensus about
timing (simultaneous or staged intervention) and
sequence (graft excision or extranatomic bypass first)
of surgical intervention.
The aim of this study was to retrospectively
evaluate early and late results of conventional mana-
gement of SAEF in our experience.
Material and Methods
From January 1990 to March 2002, 2122 aortic
reconstructions were performed at our Department;
in 1501 patients the indication for surgery was the
presence of abdominal aortic aneurysm (AAA), in 621
cases an obstructive aorto-iliac disease was present.
Data concerning thirty patients who underwent
surgical intervention due to the presence of SAEF
were collected and retrospectively inserted in a
database containing 70 fields concerning main clinical,
diagnostic and surgical parameters. Conventional
surgical treatment (graft excision, oversewing of aortic
stump, intestinal suture or resection, when necessary,
and extranatomic revascularization with axillo-bife-
moral bypass) was performed in all the patients.
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Early results in terms of mortality, patency and limb
salvage were analysed; univariate (chi square test) and
multivariate analysis (logistic regression with 95% CI)
were performed to detect factors affecting results.
Clinical and ultrasonographic follow-up with CW
Doppler and, in last five years, with Duplex scanning,
was performed at 1, 6 and 12 months and then
annually. Long-term results were evaluated by life-
table analysis (Kaplan–Meyer test); results in different
subgroup were compared by log-rank test.
Results
Cumulative incidence of SAEF in our experience was
1% (30 cases/2122 interventions). Twenty-eight
patients were males; median age was 70 years (s.d. 10)
The incidence of prosthetic graft infection with
SAEF was 2% (17/621) in patients operated on for
obstructive disease and 1% (15/1501) in patients
operated on for AAA; two patients had both AAA
and occlusive disease.
Aortofemoral aortic grafts were placed in 16
patients (53%); ten patients had an aorto-iliac bifur-
cated graft and four had a tube graft; 17 patients had
end-to-side proximal anastomosis.
Considering factors that may have contributed to
the development of aortic graft infection, the com-
monest were concomitant or subsequent gastrointes-
tinal procedures (11 patients; cholecistectomy in 5
patients, one concomitant and four subsequent; con-
comitant appendectomy in 1 patient and subsequent
bowel resection in 5) and subsequent reoperations on
aortic graft (10 patients).
Diagnostic workup
Most patients (26 cases, 87%) had signs and symptoms
of systemic infection; 21 of these patients had evidence
of gastrointestinal bleeding.
The commonest signs and symptoms of systemic
infection were hypocromic anemia (26 patients) and
fever (24 patients); leukocytosis was present in 12
patients. In eight patients, preoperative blood culture
was positive (S. aureus, 3 patients; E. coli, 3 patients; K.
pneumoniae, 2 patients).
The most common preoperative assessment con-
sisted of CT scan of the abdomen (29 patients, 97%); in
10 patients esophagogastroduodenoscopy (EGD) was
performed.
CT scan was diagnostic for aortic graft infection in
18 patients; one of these patients had also aortic false
aneurysm and two had iliac false aneurysm. Evidence
of SAEF was demonstrated in 9 patients, and, in the
remaining two, only the presence of an aortic false
aneurysm was detected.
The result of EGD was abnormal in six patients, but
it was diagnostic of SAEF in only one case (graft
material seen).
Radionuclide scanning with technetium-99-labeled
leukocytes3 was performed only in two patients and in
both it was negative.
Median cumulative time between initial aortic
grafting and diagnosis of aortic graft infection was
37 months (s.d. 58).
Surgical treatment
Surgical intervention consisted of prosthetic graft
excision and extranatomic bypass in 28 patients, as
in two patients graft excision alone was performed: in
one case the poor general status of the patient did not
allow to go on with revascularization, and one patient
who was expected to have staged treatment of its
aortic graft infection died between the first and second
stage operation. Emergent intervention was necessary
in 6 patients.
Fourteen patients had prosthetic graft excision
followed by extranatomic bypass, both under the
same anaesthesia (simultaneous intervention, 13
patients) and after a brief interval (staged intervention,
1 patient). The remaining 14 patients had extranatomic
bypass before graft excision; in 9 cases the intervention
was simultaneous and in 5 staged.
In staged interventions, median interval between
the two procedures was 3 days (s.d. 12).
Intraoperative findings showed duodenum to be
the commonest site of fistula (Table 1, Fig. 1).
All but two patients had transverse closure of bowel
defect with standard intestinal suture technique. One
patient had duodenal segmental resection with end-to-
end anastomosis and another patient, who had a large
paraprosthetic fistula with sigmoid colon, underwent
left emicolectomy with colostomy of transversus
colon.
In all the cases oversewing of aortic stump with
double suture line in ePTFE (expanded-polytetrafluor-
ethylene) was performed; aggressive excision and
debridement of the retroperitoneum and of periaortic
tissues was always performed.
Table 1. Site of fistula.
Duodenum 19 63%
Ileum 2 7%
Jejunum 7 24%
Sigmoid colon 2 6%
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The extranatomic revascularization consisted of an
axillo-bifemoral bypass in 27 patients; one patient had
an axillo-left femoral-right popliteal bypass. Ringed
ePTFE was always used.
Culture of excised graft was performed in 22
patients (Table 2).
There were eight perioperative (,30 days)
deaths; only one patient died intraoperatively.
Cumulative 30-day mortality rate was 26%; the
main cause of death was aortic stump disruption
(Table 3).
There were no significative differences in terms of
early mortality between elective or urgent interven-
tions (six and two deaths, respectively; p ¼ 0:5).
Three deaths happened when graft excision and
revascularization were staged and four when they
were simultaneous ðp ¼ 0:5Þ: As already mentioned,
one patient died between the first and second stage
operation. There were two deaths in patients
undergoing graft excision first and five in patients
with extranatomic revascularization first ðp ¼ 0:1Þ:
Multivariate analysis did not show any significa-
tive influence of the examined parameters on 30-day
mortality (Table 4).
There were six axillo-femoral bypass thromboses at
30 days, and in all the cases surgical thrombectomy
was successfully performed. No amputations occurred
perioperatively.
Long-term data
Median duration of follow-up was 10 months (s.d. 21);
during follow-up there were eight deaths (Table 3).
Estimated 12 and 24 months survival rates were 60 and
50%, respectively (Fig. 2).
During follow-up three extranatomic bypass throm-
boses happened, and primary patency rate were 80%
at 12 months and 62% at 24 months (Fig. 3). There was
only one major amputation, and 24-month limb
salvage rate was 95%.
Long-term survival was significantly better in
patients who had prosthetic graft excision first
(p ¼ 0:04; log-rank 4.03) and there was a trend towards
significancy for long-term better survival when inter-
ventions were simultaneous (p ¼ 0:08; log-rank 3.0).
The cause for initial aortic grafting and status of
femoro-popliteal axis did not influenced long-term
risk of prosthetic graft thrombosis (p ¼ 0:7; log-rank
0.12).
Two patients had symptoms and signs of extra-
natomic bypass reinfection during follow-up. One
patient had prosthetic branch thrombosis; at surgical
intervention, prosthetic branch was surrounded by
perigraft abscess and it was excised and in situ
replaced with an autologous saphenous vein bypass.
Another patient had a groin abscess, which was
drained percutaneously with complete resolution of
infection.
Thus, the evenience of reintervention during
follow-up was 4/22 patients (18%).
Discussion
Secondary aorto-enteric fistula represents a potentially
dramatic complication of reconstructive aortic surgery,
whose incidence ranges between 0.35 and 1.6%4 in
main published series; in our series the corresponding
figure is similar as well.
High mortality and amputation rates in these
patients are strictly dependent on severity of clinical
manifestations, poor general status of most patients
Fig. 1. Duodenal fistula; intraoperative finding.
Table 2. Results of excised prosthetes coltures.
Staphylococcus aureus 9 41%
Enterobacter 8 36%
Candida albicans 4 18%
Staphylococcus epidermidis 3 14%
Others 2 9%
Table 3. Perioperative and late cause of deaths.
Cause of death Perioperative Late
Aortic stump disruption 4 (13%) 3 (10%)
Sepsis 2 (6.5%) 2 (6.5%)
Intracranial hemorrage 1 (3.5%) –
Acute myocardial infarction 1 (3.5%) 1 (3.5%)
Acute renal failure – 1 (3.5%)
Unknown – 1 (3.5%)
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when diagnosis is made and magnitude of surgical
intervention.5 – 7
The treatment of choice in this situation remains
debatable, the lack of scientific evidences being
dependent on the few, retrospective published series
with small number of patients.4
Traditional surgical treatment consists of infected
graft excision, aortic stump suture and lower limb
revascularization with extranatomic bypass.
Even if the risk of perioperative death and of early
and long term aortic stump disruption and amputa-
tion with this technique is not negligible, however,
results of its use have gradually improved since its
introduction.4,8
Recently, Yeager et al.1 reported some 19% of
perioperative mortality in 16 patients with aortic
graft infection and bowel involvement: aortic stump
disruption rate in these patients was 6.2%, but no
analysis of these data was made in the subgroup of
patients with true fistula, where the corresponding
rate was likely higher.
Also in our series the rates of perioperative
mortality and aortic stump disruption were acceptably
low and similar to those in published series in last
decade. In our experience, it was possible to achieve a
satisfactory low rate of perioperative aortic stump
disruption by mean of simple two layer suture with
monofilament ePTFE of aorta at a level where it
appeared healthy and not involved by infection. We
never used any adjunctive method to protect aortic
stump, as it was proposed by several authors.9,10 It has
been suggested4 also to perform a suprarenal or
supravisceral aortic cross-clamping, to allow more
proximal aortic debridement; however, we never used
this strategy.
Fig. 2. Long-term survival (Kaplan–Meyer test; standard error 9.03) with number of patients at risk.
Table 4. Multiple regression analysis of operative risk for 30-day
death.
Risk factor Odds ratio (95% CI) P
Urgent intervention 0 0–7.3 0.9
COPD 0.7 0.03–20 0.8
CRF 0.7 0–8.2 0.9
Diabetes 0.9 0–1.9 1
CAD 0 0–9.1 0.9
Gastrointestinal bleeding 1 0.06–18.8 0.9
Staged intervention 0.6 0.03–11.8 0.7
Primary graft excision 1.2 0.05–28 0.8
Site of fistula 6.2 0–5.5 0.8
COPD, chronic obstructive pulmonary disease; CRF, chronic renal
failure; CAD, coronary artery disease.
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There is no consensus in Literature concerning the
ideal timing and sequence of surgical intervention.
The main advantage of simultaneous interventions is
to limit lower extremity ischemic time;11 staged
intervention decreases the time and magnitude of the
operation, making it two lesser operations.12 In our
experience, we did not see any difference in terms of
perioperative mortality and complications between
simultaneous and staged interventions; however,
there was a mild advantage for simultaneous inter-
vention in long-term survival rates.
When considering the sequence of surgical inter-
vention, our choice was always made on the basis of
clinical status of the patients, accordingly with
suggestions from most authors:1 patients with acute
bleeding, unstable hemodynamic status or severe
sepsis should undergo prosthetic graft excision first.
In stable patients, with previous or occult bleeding or
mild infection, lower limb revascularization should be
performed first.
Most published studies4,13 report better results in
terms of perioperative mortality in patients who
underwent extranatomic bypass first, reducing the
risk of hemodynamic and metabolic consequences of
lower limb ischemia. However, in our experience we
did not observe any difference in terms of periopera-
tive results when considering operative sequence: in
our opinion an ‘ideal’ intervention does not exist, and
the choice should be made on a single patient basis.
Long-term survival was better in patients who had
graft excision as primary intervention: we are not
aware of previous series reporting this finding, whose
explanation is rather difficult and uncertain.
Long-term failure of extranatomic bypass has been
described to be a common complication of treatment
of SAEF: Rutherford et al.14 reported a 5-year primary
patency rate of 62%; the corresponding figure was 73%
in Yeager’s series.1 Thus, our results are fairly good
and comparable with those reported in other series.
Extranatomic bypass failure was found to be more
common in patients treated for infected grafts orig-
inally placed for occlusive disease:1 however, this was
not our finding, and we did not observe any difference
in long-term patency between patients operated on for
occlusive or aneurismal disease.
Also the rate of reinfection of extranatomic bypass
Fig. 3. Long-term primary patency (Kaplan–Meyer test; standard error 7.12) with number of patients at risk.
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graft was low in our series, and only one reinterven-
tion of partial prosthetic excision was needed. Yeager
et al.1 reported a reinfection rate of 10% and Sharp
et al.9 had only one case of graft reinfection (5%); in
Ricotta’s series15 no cases of late reinfection are
described.
Cumulative reintervention rate in our experience
was 18%, and this is a lower value than those reported
in main published series.1,9
Several alternative methods to traditional technique
in treating prosthetic aortic graft infection have been
proposed in last years; however, data concerning
application of these methods in patients with SAEF
are poor.
Cryopreserved aortic allograft were used by some
authors in patients with SAEF with poor late
results.16 – 18
In situ replacement with a new graft was also
proposed19 but long-term results were poor, and, at the
moment, this approach should be reserved to low
grade aortic infections.20,21
Interesting perspectives derive from in situ replace-
ment with antibiotic or antimicrobic bonded grafts:22,
23 however, all the patients in most published series
had low-grade infection.
In situ replacement with autologous deep veins
provides encouraging results in the treatment of aortic
graft infection; however, there are very few data
concerning its use in treating SAEF.24
Finally, autologous repair with endarterectomy of
aorto-iliac axis and primary or patch closure of aorta
was anedoctically reported in patients originally
treated for occlusive disease.4
Endovascular treatment has been recently proposed
in these high-risk patients: in the largest series,25
immediate mortality rate was 14%; 3-years mortality
was 43%, with a rate of reinfection of endoprosthesis of
28%. Thus, endovascular approach, at the moment,
does not appear to be a definitive therapeutic option in
these patients: however, its use was proposed as a
temporary method to obtain a stable hemodynamic
status in patients with acute bleeding, so to perform a
safer intervention of graft excision and lower limb
revascularization, once improvement of clinical con-
ditions is obtained.26
Conclusions
Secondary aorto-enteric fistula remains a very danger-
ous complication of reconstructive aortic surgery,
whose treatment is weighed by not negligible early
and late complications, despite of improvement in
surgical and anaesthesiological techniques.
Conventional treatment with infected graft excision
and extranatomic bypass is an effective approach,
providing satisfactory early and late results.
Ideal timing and surgical sequences do not exist: the
choice must be always made after a careful evaluation
of clinical and instrumental features of the single
patient.
The effectiveness of alternative approaches, both
surgical and endovascular, should be validated
against conventional treatment.
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